Benchmark Reiterates Buy on Transphorm, Maintains $8 Price Target
Portfolio Pulse from richadhand@benzinga.com
Benchmark analyst David Williams has reiterated a 'Buy' rating on Transphorm (NASDAQ:TGAN) and maintained the price target at $8.

August 15, 2023 | 1:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Transphorm's stock rating has been reiterated as 'Buy' by Benchmark analyst David Williams, with a maintained price target of $8.
The reiteration of a 'Buy' rating by a Benchmark analyst indicates a positive outlook for Transphorm. The maintained price target of $8 suggests that the analyst believes the stock is still undervalued, which could lead to an increase in buying pressure and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100